Brief: Beyondspring Announces Organizational Streamlining
11/01/2022 21:11
Jan 11 (Reuters) - Beyondspring Inc BYSI.O :
* BEYONDSPRING ANNOUNCES ORGANIZATIONAL STREAMLINING
* BEYONDSPRING INC - 35% REDUCTION IN WORKFORCE IN U.S.
IMPLEMENTED TO PRESERVE LONG-TERM SUSTAINABILITY
* BEYONDSPRING INC - REDUCTION IN WORKFORCE IN U.S.
EXPECTED TO
RESULT IN COST SAVINGS THAT WILL EXTEND CASH RUNWAY
* BEYONDSPRING INC - REORGANIZATION FOLLOWS RECEIPT OF A
COMPLETE
RESPONSE LETTER FROM U.S. FDA FOR NEW DRUG APPLICATION SEEKING
APPROVAL OF PLINABULIN
* BEYONDSPRING INC - GOING FORWARD, INTENDS TO PRIORITIZE
CONTINUED ADVANCEMENT OF REGULATORY PROCESS OF PLINABULIN IN CIN
IN CHINA AND U.S.
* BEYONDSPRING INC - GOING FORWARD, INTENDS TO PRIORITIZE
NDA
FILING AND REGULATORY PROCESS OF NON-SMALL CELL LUNG CANCER
(NSCLC) IN U.S. AND CHINA
* BEYONDSPRING - INTENDS TO PRIORITIZE ADVANCEMENT OF
IMMUNE-ONCOLOGY (IO) TRIALS WITH PLINABULIN IN TRIPLE
COMBINATION IO THERAPY IN VARIOUS CANCERS
Source text for Eikon: ID:nGNX8zTwYz
Further company coverage: BYSI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Beyondspring
See all newsBrief: Beyondspring Inc Entered Into Open Market Sale Agreement Under Which Co May Offer And Sell Up To 9.2 Million Ordinary Shares
Brief: Beyondspring Announces FDA Fast Track Designation For Plinabulin In Post-Ici Non-Squamous Nsclc And Strategic Transaction To Advance Global Phase 3 Dublin-4 Trial Toward Planned Interim Analysis
NASDAQ RESUMED AT 12:26 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:21 PM
Brief: Beyondspring Announces Leadership Transition To Deliver Focused Execution On Its Confirmatory Dublin-4 Program And Long-Term Value